CD4 and myeloid sarcoma: In 1986, Hauser et al. studied 16 cases of progressive MS, and observed up to 50 times more CD8+ T cells in both the parenchyma and in perivascular cuffs of active lesions, with no case of more CD4+ than CD8+ T cells.